Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

[1]  K. Owzar,et al.  Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib , 2020, Molecular Cancer Therapeutics.

[2]  A. Briganti,et al.  A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. , 2020, The Journal of urology.

[3]  S. Shariat,et al.  Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis , 2020, International Journal of Clinical Oncology.

[4]  J. Witjes,et al.  European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.

[5]  S. Shariat,et al.  Differential Effect of Sex on Outcomes After Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis. , 2020, The Journal of urology.

[6]  P. Grivas,et al.  The utility of next generation sequencing in advanced urothelial carcinoma. , 2019, European urology focus.

[7]  Shahrokh F. Shariat,et al.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. , 2019, European urology.

[8]  J. Witjes,et al.  Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer , 2019, BJU international.

[9]  M. R. Kim,et al.  Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer , 2018, International journal of molecular sciences.

[10]  S. Shariat,et al.  Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer , 2018, Expert review of molecular diagnostics.

[11]  F. Mahjoubi,et al.  Study of Vcam-1 Gene Expression in Normal and Tumoral Tissues in Patients With Colorectal Cancer , 2017 .

[12]  G. Petroni,et al.  Mesothelium expression of vascular cell adhesion molecule‐1 (VCAM‐1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC) , 2017, Cancer.

[13]  M. R. Kim,et al.  A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro , 2017, International journal of molecular sciences.

[14]  A. Vickers,et al.  Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. , 2015, European urology.

[15]  G. Bendas,et al.  Vascular cell adhesion molecule‐1 (VCAM‐1)—An increasing insight into its role in tumorigenicity and metastasis , 2015, International journal of cancer.

[16]  Yair Lotan,et al.  Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. , 2015, European urology.

[17]  M. Hollstein,et al.  VEGF-A isoforms differentially regulate ATF-2–dependent VCAM-1 gene expression and endothelial–leukocyte interactions , 2014, Molecular biology of the cell.

[18]  F. Tas,et al.  Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy , 2014, Tumor Biology.

[19]  F. Montorsi,et al.  Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis. , 2013, Cancer epidemiology.

[20]  C. Dinney,et al.  Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort , 2011, BJU international.

[21]  Y. Lotan,et al.  Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. , 2010, Urologic oncology.

[22]  Yair Lotan,et al.  Statistical consideration for clinical biomarker research in bladder cancer. , 2010, Urologic oncology.

[23]  Yair Lotan,et al.  Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[24]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[25]  T. Wheeler,et al.  Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Y. Iwamoto,et al.  The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13 , 2000, The Journal of Immunology.

[27]  A. Blann,et al.  Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. , 2000, Journal of the National Cancer Institute.

[28]  Yair Lotan,et al.  Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. , 2007, European urology.

[29]  R. Hwang,et al.  Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. , 2005, The Journal of clinical investigation.